380 related articles for article (PubMed ID: 15974884)
1. Pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: candidate mechanisms for anti-lipid deposition in blood vessels.
Kumai T; Matsumoto N; Koitabashi Y; Takeba Y; Oonuma S; Sekine S; Tadokoro M; Kobayashi S
Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):195-201. PubMed ID: 15974884
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic vascular protective effects of statins in perioperative medicine.
Fang SY; Roan JN; Luo CY; Tsai YC; Lam CF
Acta Anaesthesiol Taiwan; 2013 Sep; 51(3):120-6. PubMed ID: 24148741
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
[TBL] [Abstract][Full Text] [Related]
4. Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation.
Antonopoulos AS; Margaritis M; Shirodaria C; Antoniades C
Thromb Haemost; 2012 Nov; 108(5):840-8. PubMed ID: 22872079
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of statins and related pharmacological experimental approaches.
Alegret M; Silvestre JS
Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic effects of statins on the vascular tissue.
Ikeda U; Shimada K
Curr Drug Targets Cardiovasc Haematol Disord; 2001 Jun; 1(1):51-8. PubMed ID: 12769664
[TBL] [Abstract][Full Text] [Related]
7. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.
Liao JK
Am J Cardiol; 2005 Sep; 96(5A):24F-33F. PubMed ID: 16126020
[TBL] [Abstract][Full Text] [Related]
8. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
Laufs U
Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
[TBL] [Abstract][Full Text] [Related]
9. Statins: the new aspirin?
Veillard NR; Mach F
Cell Mol Life Sci; 2002 Nov; 59(11):1771-86. PubMed ID: 12530513
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
Takemoto M; Liao JK
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1712-9. PubMed ID: 11701455
[TBL] [Abstract][Full Text] [Related]
11. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
12. Direct effects of statins on cells primarily involved in atherosclerosis.
Chen H; Ikeda U; Shimpo M; Shimada K
Hypertens Res; 2000 Mar; 23(2):187-92. PubMed ID: 10770267
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation.
Arnaud C; Mach F
Arch Mal Coeur Vaiss; 2005 Jun; 98(6):661-6. PubMed ID: 16007821
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis.
Arnaud C; Veillard NR; Mach F
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):127-34. PubMed ID: 15853754
[TBL] [Abstract][Full Text] [Related]
15. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S
Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic effects of statins: A focus on cancer.
Ahmadi M; Amiri S; Pecic S; Machaj F; Rosik J; Łos MJ; Alizadeh J; Mahdian R; da Silva Rosa SC; Schaafsma D; Shojaei S; Madrakian T; Zeki AA; Ghavami S
Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165968. PubMed ID: 32927022
[TBL] [Abstract][Full Text] [Related]
17. In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products.
Diomede L; Albani D; Sottocorno M; Donati MB; Bianchi M; Fruscella P; Salmona M
Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1327-32. PubMed ID: 11498461
[TBL] [Abstract][Full Text] [Related]
18. [HMG-CoA reductase inhibitors: anti-atherosclerotic effects other than lipid-lowering].
Fujita R; Matsushima T
Nihon Rinsho; 1999 Dec; 57(12):2821-5. PubMed ID: 10638219
[TBL] [Abstract][Full Text] [Related]
19. Statins and bone formation.
Garrett IR; Gutierrez G; Mundy GR
Curr Pharm Des; 2001 May; 7(8):715-36. PubMed ID: 11405194
[TBL] [Abstract][Full Text] [Related]
20. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Istvan ES
Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
